Effect of concomitant statin use on rituximab treatment for pemphigus and pemphigoid disorders: a case‐based review

Abstract

Journal of the European Academy of Dermatology and VenereologyVolume 28, Issue 4 p. 520-522 Letter to the Editor Effect of concomitant statin use on rituximab treatment for pemphigus and pemphigoid disorders: a case-based review K. Heelan, K. Heelan Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, CanadaSearch for more papers by this authorS. Knowles, S. Knowles Division of Clinical Pharmacology and Toxicology at Sunnybrook, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Canada Department of Pharmacology, Sunnybrook Health Sciences Centre, University of Toronto, CanadaSearch for more papers by this authorS. Walsh, S. Walsh Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, CanadaSearch for more papers by this authorN.H. Shear, Corresponding Author N.H. Shear Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Canada Division of Clinical Pharmacology and Toxicology at Sunnybrook, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, CanadaCorrespondence: N.H. Shear. E-mail: neil.shear@sunnybrook.caSearch for more papers by this author K. Heelan, K. Heelan Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, CanadaSearch for more papers by this authorS. Knowles, S. Knowles Division of Clinical Pharmacology and Toxicology at Sunnybrook, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Canada Department of Pharmacology, Sunnybrook Health Sciences Centre, University of Toronto, CanadaSearch for more papers by this authorS. Walsh, S. Walsh Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, CanadaSearch for more papers by this authorN.H. Shear, Corresponding Author N.H. Shear Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Canada Division of Clinical Pharmacology and Toxicology at Sunnybrook, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, CanadaCorrespondence: N.H. Shear. E-mail: neil.shear@sunnybrook.caSearch for more papers by this author First published: 24 July 2013 https://doi.org/10.1111/jdv.12217Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Volume28, Issue4April 2014Pages 520-522 RelatedInformation